Evaluation of Cognitive Impairment and Neurotoxicity Post CAR-T Cell Therapy.
Evlampia Strongyli(G. Papanikolaou General Hospital), Ioanna Sakellari(Aristotle University of Thessaloniki), Zoi Bousiou(G. Papanikolaou General Hospital), Christos Demosthenous(G. Papanikolaou General Hospital), Maria Gavriilaki(Aristotle University of Thessaloniki), Eleni Gavriilaki(Aristotle University of Thessaloniki), Ioannis Kyriakou(G. Papanikolaou General Hospital), Paschalis Evangelidis(Aristotle University of Thessaloniki), Marianna Masmanidou(G. Papanikolaou General Hospital), Ioannis Batsis(G. Papanikolaou General Hospital), Sotirios Papagiannopoulos(G. Papanikolaou General Hospital), Panagiotis Dolgyras(G. Papanikolaou General Hospital), Vasilios Κ. Kimiskidis(Aristotle University of Thessaloniki), Anna Vardi(G. Papanikolaou General Hospital), Damianos Sotiropoulos(G. Papanikolaou General Hospital), Evangelia Yannaki(G. Papanikolaou General Hospital), Despina Mallouri(G. Papanikolaou General Hospital), Dimitrios Kazis(G. Papanikolaou General Hospital), Ioannis Giokaris(G. Papanikolaou General Hospital), Asimina Bouinta(G. Papanikolaou General Hospital)
Cited by 0
Related Papers
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)
|Clinical Neurophysiology|2014|2.2k
Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines
|Clinical Neurophysiology|2020|1.5k
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
|JAMA Neurology|2017|274